Roy Galvin - Oct 31, 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
EVP, Chief Commercial Officer
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Galvin
Stock symbol
HAE
Transactions as of
Oct 31, 2025
Transactions value $
-$7,251
Form type
4
Date filed
11/3/2025, 04:19 PM
Previous filing
Jun 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Galvin Roy EVP, Chief Commercial Officer 125 SUMMER STREET, BOSTON /s/ Thomas V. Powers, attorney-in-fact for Mr. Galvin 2025-11-03 0001950021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Tax liability -$7.25K -145 -1.12% $50.01 12.8K Oct 31, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
F2 This number includes unvested RSUs previously reported as well as 24 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2025.